PLEASANTON, Calif., Oct. 30, 2013 -- /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported its financial results for the third quarter of 2013.
“Thoratec generated strong results during the third quarter, highlighted by continued growth in our HeartMate II® and CentriMag® product lines,” said Gary F. Burbach, President and Chief Executive Officer.
Help employers find you! Check out all the jobs and post your resume.
